Johnson pharmacare Limited has announced a significant board-level change following a meeting held on January 31, 2026. The company's Board of Directors convened from 6:10 p.m. to 6:40 p.m. to address the resignation of a key executive director.

Director Resignation Details

The board approved the resignation of Mr. Umesh Kumar (DIN: 07015921) from his position as Additional & Executive Director, effective January 31, 2026. The resignation was submitted under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Confirmation

Johnson Pharmacare Limited received formal confirmation from Mr. Umesh Kumar stating that there are no other material reasons for his resignation beyond those provided in his resignation letter. In his formal resignation communication, Mr. Kumar cited personal and unavoidable reasons as the basis for stepping down from his role.

The resignation letter addressed to the Board of Directors specifically mentioned his departure from the Board of Directors and respective Board Committees where he served as a member. Mr. Kumar requested the board to complete all necessary formalities under the Companies Act, 2013, and LODR regulations.

Additional Directorships

According to the company's disclosure, Mr. Umesh Kumar holds directorship in one other listed entity:

• Space Incubatrics Technologies Limited - serving in a professional capacity

Regulatory Compliance

The announcement was made in compliance with SEBI regulations, with the disclosure submitted to BSE Limited under scrip code 532154. The company's registered office is located in Ahmedabad, Gujarat, while its corporate office operates from New Delhi.

Rajender Parsad, Additional Director (DIN: 10871533), signed the disclosure on behalf of the Board of Directors, ensuring proper documentation and regulatory compliance for the directorial change.

Johnson Pharmacare Limited has announced the resignation of two directors from its board, both effective January 21, 2026. The pharmaceutical company disclosed these changes in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Resignations Overview

The company experienced simultaneous departures from its board leadership on January 21, 2026. Both resignations were attributed to personal and unavoidable reasons, with formal documentation submitted to BSE Limited.

Regulatory Compliance and Confirmations

Johnson Pharmacare Limited confirmed receipt of formal resignation letters from both directors. The company stated that it received confirmation from both Mr. Rajender Parsad and Ms. Parul Agrawal that there were no other material reasons for their resignations beyond those provided in their formal submissions.

The resignations were processed in accordance with the provisions of the Companies Act, 2013, and SEBI (LODR) Regulations. Additional Director Umesh Kumar (DIN: 07015921) signed the disclosure documents on behalf of the Board of Directors.

Directors' Other Commitments

Both resigning directors maintain positions with other listed entities. The disclosure revealed their external directorship commitments:

Company Information

Johnson Pharmacare Limited operates with its registered office located at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad, Gujarat. The company's corporate office is situated at 1002 10th Floor, Vikram Tower, Rajendra Place, New Delhi. The company trades on BSE under scrip code 532154 with ISIN INE560F01022.

The formal disclosure documents were submitted to BSE Limited's Department of Corporate Service, ensuring compliance with all regulatory requirements for director changes. Both resignations became effective during working hours on January 21, 2026, marking a significant change in the company's board composition.